Case Report: The First Case of Paradoxical Skin Lesions Induced by Xeligekimab in a Patient With SAPHO Syndrome

Int J Rheum Dis. 2026 Apr;29(4):e70643. doi: 10.1111/1756-185x.70643.
No abstract available

Publication types

  • Letter